MORGANTOWN, W.Va., Jan. 7, 2015 (GLOBE NEWSWIRE) -- Protea Biosciences Group, Inc. (OTCQB:PRGB) ("Protea", "the Company") announced today that Stephen Turner, CEO and Chairman, will be presenting at the Biotech Showcase™ 2015 Conference being held in San Francisco, CA.
Mr. Turner will provide an overview of Protea's technology and business during his presentation and will be available to participate in one-on-one meetings.
Details of Protea Biosciences' presentation are as follows:
|Event:||Biotech Showcase™ 2015 Conference|
|Date:||Monday, January 12, 2015|
|Time:||8:00 AM PST|
|Location:||Hearst Room: Parc 55 Wyndham San Francisco Union Square Hotel|
The presentation will be webcast live and remain available for 180 days following the presentation. To access the webcast, please visit the investor relations page of Protea Biosciences' website at https://proteabio.com/investors.
About Protea Biosciences
Protea Biosciences Group, Inc. (OTCQB:PRGB) is a molecular information company providing innovative bioanalytical solutions to the pharmaceutical and life science industries. "Molecular information" refers to the generation and bioinformatic processing of very large data sets, obtained by applying the Company's technology to identify and characterize the proteins, metabolites, lipids and other biomolecules which are the byproducts of all living cells and life forms.
The Company is applying its technology to the development of next generation, "direct molecular imaging" technology and service capabilities that enable more rapid and comprehensive molecular profiling of human disease.
About the Biotech Showcase™ 2015 Conference
Co-produced by Demy-Colton Life Science Advisors and EBD Group, Biotech Showcase is an investor and partnering conference devoted to providing private and public biotechnology and life sciences companies an opportunity to present to, and meet with, investors and pharmaceutical executives during the course of one of the industry's largest annual healthcare investor conferences. Now in its seventh year, Biotech Showcase is expected to attract upwards of 1,500 attendees.
This press release may contain statements relating to future results or events, which are forward-looking statements. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes" and words of similar import may identify forward-looking statements. These statements are not historical facts, but instead represent only the Company's belief regarding future events, many of which, by their nature, are inherently uncertain and outside of the Company's control. It is possible that the Company's actual results and financial condition may differ, possibly materially, from the anticipated results and financial condition indicated in these forward-looking statements. Further, information concerning the Company and its business, including factors that potentially could materially affect the Company's business and financial and other results, are contained in the Company's filings with the Securities and Exchange Commission, available at www.sec.gov. All forward-looking statements included in this press release are made only as of the date of this press release, and we do not undertake any obligation to publicly update or correct any forward-looking statements to reflect events or circumstances that subsequently occur or of which we hereafter become aware.
CONTACT: For More Information: Protea Biosciences Group, Inc., 955 Hartman Run Road, Morgantown, WV 26505 Phone: (304) 292-2226 Fax: (304) 292-7101 Steve.firstname.lastname@example.org
Source:Protea Biosciences, Inc.